DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
TAMPA, FL / ACCESS Newswire / November 2, 2026 / DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company")(NASDAQ:MEDS), a healthcare company that integrates its health…
DO
By Daniel Okafor · Regulatory Correspondent
Nov 2 06:01 ETSource: The Batesville Daily Guard
From the source
Read at guardonline.comDataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
TAMPA, FL / ACCESS Newswire / November 2, 2026 / DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company")(NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx™ artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that its pharmacy-focused subsidiary Core
